Cargando…
Patent Pooling for Promoting Access to Antiretroviral Drugs (ARVs) – A Strategic Option for India
The current HIV/AIDS scenario in India is quite grim with an estimated 2.4 million people living with HIV/AIDS (PLHA) in 2008, just behind South Africa and Nigeria. The anti-retroviral drugs (ARVs) remain the main stay of global HIV/AIDS treatment. Over 30 ARVs (single and FDCs) available under six...
Autores principales: | Satyanarayana, Kanikaram, Srivastava, Sadhana |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Bentham Open
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2819698/ https://www.ncbi.nlm.nih.gov/pubmed/20148091 http://dx.doi.org/10.2174/1874613601004020041 |
Ejemplares similares
-
Pooling ARV Drug Patents: A Pro-Access Fitting Strategy?
por: Dionisio, Daniele
Publicado: (2010) -
Patent Pools for ARVs: Industry Perspectives from ASPEN
por: Nicolaou, Stavros
Publicado: (2010) -
Technology Development Through Pooling ARV Drug Patents: A Vision from China
por: Liu, Li, et al.
Publicado: (2010) -
Designing ARVs Patent Pool Up to Trade & Policy Evolutionary Dynamics
por: Dionisio, Daniele, et al.
Publicado: (2010) -
Implications of Patent Pools on Innovation Regarding Antiretrovirals
por: Noehrenberg, Eric
Publicado: (2010)